Tech Company Financing Transactions
Iambic Therapeutics Funding Round
Iambic Therapeutics, based in San Diego, secured $100 million from Abingworth, Ascenta Capital and Catalio Capital Management.
Transaction Overview
Company Name
Announced On
10/6/2023
Transaction Type
Venture Equity
Amount
$100,000,000
Round
Series B
Investors
Proceeds Purpose
The company intends to use the funds to advance multiple candidates into clinical development, expand its pipeline with additional candidates with best-in-class and first-in-class potential, and continue to innovate and build next-generation AI and automation technologies for drug discovery. It plans to leverage NVIDIA technology such as the NVIDIA DGX Cloud AI supercomputing platform and the NVIDIA BioNeMo cloud service to accelerate discovery.
Company Information
Company Status
Private & Independent
Industry
AdTech
Mailing Address
5627 Oberlin Drive 120
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Undisclosed
Website
Email Address
Overview
Our physics-based AI algorithms drive a high-throughput experimental platform, converting new molecular designs to new biological insights each week.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Tom Miller
Chief Technical Officer
Fred Manby
Browse more venture capital transactions:
Prev: 10/6/2023: Breathe Battery Technologies venture capital transaction
Next: 10/6/2023: Diana Health venture capital transaction
Share this article
Where The Data Comes From
We report on all VC transactions involving tech companies. VC investment data records reported here are derived from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs